MeiraGTx Hldgs Stock (NASDAQ:MGTX), Quotes and News Summary

Q: What sector and industry does MeiraGTx Hldgs (MGTX) operate in?

MeiraGTx Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MeiraGTx Hldgs Stock (NASDAQ: MGTX) stock price, news, charts, stock research, profile.

Open	$4.910
Close	-
Volume / Avg.	87.508K / 147.867K
Day Range	4.770 - 4.935
52 Wk Range	3.490 - 8.350
Market Cap	$316.591M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	2.4%
Days to Cover	8.45

Recent News

Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

Avi Kapoor

Why Is Eye Disease Related Gene Therapy Focused MeiraGTx Stock Soaring Today?

MeiraGTx Holdings plc (NASDAQ: MGTX) on Thursday announced an asset purchase agreement with Janssen Pharmaceuticals Inc, a Johnson & Johnson (NYSE: JNJ) compan

Vandana Singh

Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About MeiraGTx Holdings plc

Sector

Health Care

Industry

Biotechnology

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary glan...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MeiraGTx Hldgs (MGTX) stock?

You can purchase shares of MeiraGTx Hldgs (NASDAQ: MGTX) through any online brokerage.

View our list of the best stock brokerages.

Who are MeiraGTx Hldgs's (MGTX) competitors?

Other companies in MeiraGTx Hldgs’s space includes: Renovaro (NASDAQ:RENB), Precigen (NASDAQ:PGEN), Adaptimmune Therapeutics (NASDAQ:ADAP), TScan Therapeutics (NASDAQ:TCRX) and RAPT Therapeutics (NASDAQ:RAPT).

What is the target price for MeiraGTx Hldgs (MGTX) stock?

The latest price target for MeiraGTx Hldgs (NASDAQ: MGTX) was reported by RBC Capital on Friday, March 15, 2024. The analyst firm set a price target for 11.00 expecting MGTX to rise to within 12 months (a possible 123.12% upside). 4 analyst firms have reported ratings in the last year.

Current Stock Price for MeiraGTx Hldgs (MGTX)?

The stock price for MeiraGTx Hldgs (NASDAQ: MGTX) is $4.93 last updated April 23, 2024 at 4:01 PM EDT.

Does MeiraGTx Hldgs (MGTX) pay a dividend?

There are no upcoming dividends for MeiraGTx Hldgs.

When is MeiraGTx Hldgs (NASDAQ:MGTX) reporting earnings?

MeiraGTx Hldgs’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is MeiraGTx Hldgs (MGTX) going to split?

There is no upcoming split for MeiraGTx Hldgs.

What sector and industry does MeiraGTx Hldgs (MGTX) operate in?

MeiraGTx Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-